Neural Analytics touts 95% accuracy for TCD platform in Expedite trial

Neural Analytics today released initial results from the Expedite study of its Transcranial Doppler Tech platform, touting 95% accuracy in the early detection of acute ischemic stroke due to large vessel occlusion. Data from the study was presented at the 26th annual European Stroke Conference this week in Berlin. The 45-subject trial examined the use of TCD scans in patients experiencing computer tomography angiography confirmed acute ischemic stroke due to large vessel occlusion of the internal carotid artery or middle cerebral artery. Scans with the TCD platform were analyzed with 2 different stroke assessment algorithms, which both reported 96% accuracy for assessing large vessel occlusions. “We are encouraged by these study results, demonstrating that under research our novel TCD platform may prove to bridge the significant gap in current stroke detection and management. Today, fewer than 10 percent of eligible stroke patients are treated surgically due to the lack of a portable diagnostic device for early detection which would enable earlier stroke diagnoses for first responders and ER physicians,” chief scientific officer Dr. Robert Hamilton said in a prepared statement. “Current standard of care for stroke diagnosis can be expensive and time consuming, underscoring a significant unmet need for an improved method for first responders and ER physicians to rapidly and accurately assess and triage patients for appropriate clinical intervention. These re...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Diagnostics Neurological Ultrasound Neural Analytics Source Type: news